Abstract
Efficacy and Safety of Adjunctive Brivaracetam (BRV) for Partial-Onset (Focal) Seizures (POS) in Patients with Type IC Seizures at Baseline: Pooled Results from Three Fixed-Dose, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies (P2.042)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
